======= MOCS1 =======
== Gene Information ==
* **Official Symbol**: MOCS1
* **Official Name**: molybdenum cofactor synthesis 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4337|4337]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZB8|Q9NZB8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MOCS1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MOCS1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603707|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Molybdenum cofactor biosynthesis is a conserved pathway leading to the biological activation of molybdenum. The protein encoded by this gene is involved in this pathway. This gene was originally thought to produce a bicistronic mRNA with the potential to produce two proteins (MOCS1A and MOCS1B) from adjacent open reading frames. However, only the first open reading frame (MOCS1A) has been found to encode a protein from the putative bicistronic mRNA, whereas additional splice variants are likely to produce a fusion between the two open reading frames. This gene is defective in patients with molybdenum cofactor deficiency, type A. A related pseudogene has been identified on chromosome 16. [provided by RefSeq, Nov 2017].
* **UniProt Summary**: N/A
|Mob synth C|
|Radical SAM|
|cyclic pyranopterin monophosphate synthase activity|
|GTP 3,8-cyclase activity|
|molybdopterin synthase complex|
|Mo-molybdopterin cofactor biosynthetic process|
|Mo-molybdopterin cofactor metabolic process|
|molybdopterin cofactor biosynthetic process|
|prosthetic group metabolic process|
|molybdopterin cofactor metabolic process|
|4 iron, 4 sulfur cluster binding|
|coenzyme biosynthetic process|
|cofactor biosynthetic process|
|coenzyme metabolic process|
|GTP binding|
|cofactor metabolic process|
|organophosphate biosynthetic process|
|organophosphate metabolic process|
|heterocycle biosynthetic process|
|organic cyclic compound biosynthetic process|
|organonitrogen compound biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp218|A-395 10μM R05 exp218]]|-1.8|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.445|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9774
* **Expression level (log2 read counts)**: -5.01
{{:chemogenomics:nalm6 dist.png?nolink |}}